Bull of the Day: Centrus Energy Corp. (LEU)

Centrus Energy (LEU) won a $900 million DOE task order to expand its Piketon enrichment facility for commercial-scale HALEU and reports $2.3 billion in contingent LEU purchase commitments from utilities while partnering with SMR developers such as TerraPower. The company delivered strong top-line momentum (sales +38% in 2024, +9% in 2023) and raised earnings revisions (2026 EPS estimate up ~10%, FY25/FY26 EPS above consensus, Q4 2025 EPS ~40% higher), earning a Zacks Rank #1. Management projects revenue growth of roughly 2% in 2025 and 10% in 2026, and the stock has risen ~1,350% over five years (though ~25% below mid-October peaks), positioning Centrus as a key beneficiary of U.S. policy to onshore uranium enrichment and increasing power demand from AI infrastructure.

Analysis

Market structure: Centrus (LEU) and US enrichment/HALEU suppliers are clear winners — utilities, SMR developers (e.g., TerraPower) and AI hyperscalers (MSFT, GOOGL, AMZN, META) gain reliable baseload optionality; incumbent Russian/Kazakhstan enrichment oligopolies lose pricing leverage as the U.S. onshores capacity. Expect enrichment pricing power to shift gradually: contractual LEU/HALEU deals (>$2.3bn contingent) compress spot volatility but support higher long-run uraniumservice margins over 3–10 years.

Risk assessment: Key tail risks are DOE funding reversal or political pushback, construction/permit delays at Piketon, and financing shortfalls for capacity expansion — any of which could erase >50% of forward EBITDA in a 12–24 month window. Near-term (days–months) volatility will hinge on financing milestones and DOE regulatory approvals; longer-term (3–10 years) outcome ties to pace of SMR builds and AI-driven grid demand (forecast +25% US electricity by 2030).

Trade implications: Favor concentrated exposure to Centrus equity and convex long-dated call exposure while hedging mining/spot risk; enrichment cashflows are more defensive than miners. Cross-asset: rising nuclear capex lifts industrials and uranium spot, may modestly steepen long-end Treasuries if funded by additional issuance; expect pick-up in options implied vols around milestone announcements.

Contrarian angles: Consensus underweights execution and financing risk — market prices LEU as a near-certain winner despite contingent $2.3bn sales. A mispriced outcome: stop-loss insensitive retail buying could create mean-reversion opportunities on 30–50% pullbacks; historical parallel — contractor-led energy rebuilds often see multi-year slippage before payoff (renewables build cycles).

Key Decisions for Investors

• Establish a 1.5–3% portfolio long position in LEU for 3–5 year hold targeting asymmetric upside from DOE-backed HALEU revenue; add another 1% on a confirmed financing close or on a 20% pullback from current levels, set initial stop-loss at -25% for the tactical tranche.
• Buy LEU 12–24 month LEAP calls (size 0.5–1% of portfolio) ~30–50% OTM to capture convex upside if HALEU commercial ramp meets 12–24 month milestones; cap total options premium risk to 1% of portfolio and roll on positive catalysts.
• Implement a pair trade: long LEU (1–2%) vs short CCJ (0.5–1%) to isolate enrichment/contract risk from spot-mining exposure — trim short if uranium spot premium widens >40% year-over-year or if CCJ issues positive production guidance.
• Take a smaller opportunistic 0.5–1% long in UUUU for leveraged uranium upstream exposure but limit drawdown to -30% and exit if DOE financing for Centrus is delayed >180 days or if LEU announces >20% capex overruns.